Future research into non-Hodgkin lymphoma treatments needs to explore long-term outcomes and a better understanding biologic ...

Despite holding promise in a range of disease states, a variety of challenges prevent cell and gene therapies (CGTs) from ...

New respiratory syncytial virus (RSV) prevention products significantly reduce infant hospitalization rates, highlighting the ...

Patients with HIV can take both their antiretroviral therapy (ART) and treatment to prevent tuberculosis safely to prevent ...

Telisotuzumab vedotin (Teliso-V) gained FDA approval as a targeted therapy for patients with advanced non–small cell lung ...

A new single-use device reduces surgical site infections, improves recovery, and lowers costs after Cesarean (C-section) ...

The study, which used flow cytometry rather than molecular biology to identify circulating tumor cells (CTCs), found a ...

RWJBarnabas Health and Rutgers Cancer Institute unveil the Jack & Sheryl Morris Cancer Center—1 of only 13 freestanding ...

"The newer medications that are coming out, and a lot of them are approved, are much more focused on the problem," explains ...

A higher composite dietary antioxidant index was found to decrease the chances of American adults developing cataracts.

Offspring born to mothers with prepregnancy obesity, gestational diabetes, or hypertensive disorders of pregnancy had higher ...

Delandistrogene moxeparvovec (Elevidys; Sarepta Therapeutics) appeared to protect muscle from progressive damage in patients ...